15.12.2016 RHÖN-KLINIKUM AG  DE0007042301

DGAP-News: RHÖN-KLINIKUM AG: Negotiations with Universities of Giessen and Marburg as well as with Federal State of Hesse on Separate Accounting at Point of Failure


 
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Miscellaneous RHÖN-KLINIKUM AG: Negotiations with Universities of Giessen and Marburg as well as with Federal State of Hesse on Separate Accounting at Point of Failure 15.12.2016 / 09:32 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Corporate News Negotiations with Universities of Giessen and Marburg as well as with Federal State of Hesse on Separate Accounting at Point of Failure Lengthy Arbitration and Court Proceedings Appear Inevitable Continued Subsidy for Research and Teaching at the Expense of Medical Care Bad Neustadt, 15th December 2016 It appears following the latest meeting with representatives of the Universities and the Federal State Government of Hesse that it will not be possible to come to an agreement regarding separate accounting for the University Hospitals in Giessen and Marburg. It therefore seems to RHÖN KLINIKUM AG as if lengthy arbitration and court proceedings will be inevitable. "The latest agreement with the Universities was in 2008/2009. Since then all our efforts to come to an agreement with the Universities and the Federal State of Hesse regarding appropriate financing of state tasks have remained fruitless," Dr. Martin Siebert, CEO of RHÖN-KLINIKUM AG, stated. This not only leads to RHÖN-KLINIKUM's receivables vis-à-vis the Universities and the Federal State of Hesse increasing every year due to growing material and personnel costs. It also means that there is no regulation for the future either: the foreseeable higher costs for research and teaching cannot be financed in the long-term on the basis of an out-of- date agreement. There is already an annual total deficit of roughly EUR 25 million currently being borne by UKGM GmbH. "Having evaluated the negotiations we have reached a point where we can no longer accept a fact confirmed by external expert opinions: that we help to finance research and teaching with funds designated for medical care, ultimately to the detriment of patients. While the University hospital in Frankfurt/Main which is fully owned by the Federal State of Hesse is granted umpteen millions of Euros every year, our negotiations with the Federal State of Hesse and the universities have come to a standstill," Dr. Siebert added. "We are convinced that we will be able to assert our justified claims in the forthcoming arbitration and court proceedings," Dr. Siebert continued. However, future investments which are necessary both at Giessen and Marburg are put at extreme risk by the looming stalemate. "Nevertheless we do not wish to break off negotiations but prefer a constructive out-of-court solution rather than a lengthy legal dispute." Our core aim remains the best possible medical care for patients at both University Hospitals as well as maintaining and enhancing both sites in the long-term and thus also safeguarding the roughly 10,000 jobs. We also wish to preserve Giessen and Marburg as research centres in the centre of Germany with a significant future potential and high performance capability. For a Better Understanding of the Subject Matter: In 2006 RHÖN-KLINIKUM AG took over 95 % of the shares in the University Hospitals in Giessen and Marburg which were merged into UKGM GmbH. UKGM has since undertaken extensive tasks in research and teaching and has received the same payment from both universities since 2008 and 2009 which does not take account of personnel and material costs which have been increasing since this time. *************************************************************************** RHÖN-KLINIKUM AG AG is one of the largest healthcare providers in Germany. At five medical sites with a total of 5,300 beds we offer cutting-edge medical care with a direct link to universities and research institutes. Our top five key areas of treatment are cardiological and coronary disease, neurological disorders, oncology, lung diseases as well as orthopedic and accident surgery. A total of over 16,000 employees work for RHÖN-KLINIKUM AG. Our facilities are located in Bad Berka, Bad Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg. Further information is available at: www.rhoen-klinikum-ag.com. Your Contact Persons: RHÖN-KLINIKUM AG Achim Struchholz Group Division Head of Corporate Communication Schlossplatz 1 97616 Bad Neustadt / Saale Telephone: + 49 - 9771 65-1327 Facsimile: + 49 - 9771 65-1820 E-mail: [email protected] Dr. Kai G. Klinger Goup Division Head of Investor Relations & Group Financing Schlossplatz 1 97616 Bad Neustadt / Saale Telephone: + 49 - 9771 65-1318 Facsimile: + 49 - 9771 99-1736 E-mail: [email protected] --------------------------------------------------------------------------- 15.12.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Salzburger Leite 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: [email protected] Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange End of News DGAP News Service --------------------------------------------------------------------------- 529965 15.12.2016


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.510,00
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 107,50
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 41,00
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,72
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 35,00
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,32
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 0,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,51
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 11,000 Halten 736,59
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
15,28 27,78 0,54 18,97
KBV KCV KUV EV/EBITDA
0,60 17,84 0,51 7,66
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,15 1,36 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 09.11.2023 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,99% -2,46% 10,00% -12,35%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM AG  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK